TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HUMANIZED ANTI-TAC - AN ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR

被引：0
|
作者：
ANASETTI, C
HANSEN, JA
WALDMANN, TA
APPELBAUM, FR
DAVIS, J
DEEG, HJ
DONEY, K
MARTIN, PJ
NASH, R
STORB, R
SULLIVAN, KM
WITHERSPOON, RP
BINGER, MH
CHIZZONITE, R
HAKIMI, J
MOULD, D
SATOH, H
LIGHT, SE
机构：
[1] NIH, METAB BRANCH, BETHESDA, MD 20892 USA
[2] HOFFMANN LA ROCHE INC, NUTLEY, NJ 07110 USA
来源：
BLOOD | 1994年 / 84卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1320 / 1327
页数：8
相关论文
共 50 条
  • [1] Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
    Przepiorka, D
    Kernan, NA
    Ippoliti, C
    Papadopoulos, EB
    Giralt, S
    Khouri, I
    Lu, JG
    Gajewski, J
    Durett, A
    Cleary, K
    Champlin, R
    Andersson, BS
    Light, S
    BLOOD, 2000, 95 (01) : 83 - 89
  • [2] PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE BY MONOCLONAL-ANTIBODY TO INTERLEUKIN-2 RECEPTOR
    BLAISE, D
    MARANINCHI, D
    MAWAS, C
    STOPPA, AM
    HIRN, M
    GUYOTAT, D
    ATTAL, M
    REIFERS, J
    LANCET, 1989, 1 (8650): : 1333 - 1334
  • [3] A HUMANIZED ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR
    QUEEN, C
    SCHNEIDER, WP
    SELICK, HE
    PAYNE, PW
    LANDOLFI, NF
    DUNCAN, JF
    AVDALOVIC, NM
    LEVITT, M
    JUNGHANS, RP
    WALDMANN, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 10029 - 10033
  • [4] Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease
    Miyamoto, T
    Akashi, K
    Hayashi, S
    Gondo, H
    Murakawa, M
    Tanimoto, K
    Harada, M
    Niho, Y
    BONE MARROW TRANSPLANTATION, 1996, 17 (02) : 185 - 190
  • [5] CRITICAL ROLE OF INTERLEUKIN-2 IN THE DEVELOPMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
    VIA, CS
    FINKELMAN, FD
    INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) : 565 - 572
  • [6] BLOCKADE OF THE INTERLEUKIN-2 RECEPTOR BY ANTI-TAC ANTIBODY - INHIBITION OF HUMAN-LYMPHOCYTE ACTIVATION
    DEPPER, JM
    LEONARD, WJ
    ROBB, RJ
    WALDMANN, TA
    GREENE, WC
    JOURNAL OF IMMUNOLOGY, 1983, 131 (02): : 690 - 696
  • [7] Serum soluble interleukin-2 receptor levels as predictive parameter of acute graft-versus-host disease
    De Souza, C
    Visentainer, J
    Lieber, S
    Favarelli, M
    Vigorito, A
    Aranha, F
    Eid, K
    Oliveira, G
    Miranda, E
    BONE MARROW TRANSPLANTATION, 2002, 29 : S198 - S198
  • [8] INTERLEUKIN-2 RECEPTOR BLOCKADE BY ANTI-TAC ANTIBODY INHIBITS IFN-GAMMA INDUCTION
    CROLL, AD
    WILKINSON, MF
    MORRIS, AG
    CELLULAR IMMUNOLOGY, 1985, 92 (01) : 184 - 189
  • [9] Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody
    Hatano, Ryo
    Ohnuma, Kei
    Yamamoto, Junpei
    Dang, Nam H.
    Yamada, Taketo
    Morimoto, Chikao
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 263 - 277
  • [10] Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease
    Shen, Meng-Zhu
    Li, Jing-Xia
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Hong, Shen-Da
    Mo, Xiao-Dong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345